The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Open accessAbstract
CONTEXT: Identification and replication of susceptibility genes for Parkinson disease at the population level have been hampered by small studies with potential biases. Alpha-synuclein (SNCA) has been one of the most promising susceptibility genes, but large-scale studies have been lacking. OBJECTIVE: To determine whether allele-length variability in the dinucleotide repeat sequence (REP1) of the SNCA gene promoter is associated with Parkinson disease susceptibility, whether SNCA promoter haplotypes are associated with Parkinson disease, and whether REP1 variability modifies age at onset. DESIGN, SETTING, AND PARTICIPANTS: We performed a collaborative analysis of individual-level data on SNCA REP1 and flanking markers in patients with Parkinson disease and controls. Study site recruitment, data collection, and analyses were performed between April 5, 2004, and December 31, 2005. Eighteen participating sites of a global genetics consortium provided clinical data. Genotyping was performed for SNCA REP1, -770, and -116 markers at individual sites; however, each site also provided 20 DNA samples for regenotyping centrally. MAIN OUTCOME MEASURES: Measures included estimations of Hardy-Weinberg equilibrium in controls; a test of heterogeneity; analyses for association of single variants or haplotypes; and survival analyses for age at onset. RESULTS: Of the 18 sites, 11 met stringent criteria for concordance with Hardy-Weinberg equilibrium and low genotyping error rate. These 11 sites provided complete data for 2692 cases and 2652 controls. There was no heterogeneity across studies (P>.60). The SNCA REP1 alleles differed in frequency for cases and controls (P<.001). Genotypes defined by the 263 base-pair allele were associated with Parkinson disease (odds ratio, 1.43; 95% confidence interval, 1.22-1.69; P<.001 for trend). Multilocus haplotypes differed in frequency for cases and controls (global score statistic, P<.001). Two-loci haplotypes were associated with Parkinson disease only when they included REP1 as one of the loci. However, genotypes defined by REP1 alleles did not modify age at onset (P = .55). CONCLUSION: This large-scale collaborative analysis demonstrates that SNCA REP1 allele-length variability is associated with an increased risk of Parkinson disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
Wacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Core assessment program for intracerebral transplantations (CAPIT)
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., & Watts, R. (1992) · Movement Disorders · doi:10.1002/mds.870070103 · Cited by 1,008
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Outeiro, T. F., & Lindquist, S. (2003) · Science · doi:10.1126/science.1090439 · Cited by 806
(2004) · doi:10.1002/ana.10846 · Cited by 614
The Future of Association Studies: Gene-Based Analysis and Replication
Neale, B. M., & Sham, P. C. (2004) · The American Journal of Human Genetics · doi:10.1086/423901 · Cited by 606
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 511
Self-citationHigh-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
Self-citationSalanti, G., Amountza, G., Ntzani, E. E., & Ioannidis, J. P. A. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201410 · Cited by 371
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
Nishioka, K., Hayashi, S., Farrer, M. J., Singleton, A. B., Yoshino, H., Imai, H., Kitami, T., Sato, K., Kuroda, R., Tomiyama, H., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20753 · Cited by 316
Genetic associations: false or true?
Ioannidis, J. P. A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00030-3 · Cited by 289
Trikalinos, T. A., Salanti, G., Khoury, M. J., & Ioannidis, J. P. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj046 · Cited by 278
Kr�ger, R., Menezes Vieira-Saecker, A. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x · Cited by 277
UCHL1 is a Parkinson's disease susceptibility gene
Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 262
Self-citationA road map for efficient and reliable human genome epidemiology.
The Human Genome Epidemiology Network and the Network of Investigator Networks, Ioannidis, J. P. A., Gwinn, M., Little, J., Higgins, J. P. T., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., et al. (2006) · Nature Genetics · doi:10.1038/ng0106-3 · Cited by 244
Self-citationChiba-Falek, O. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3101 · Cited by 242
Multiple regions of α‐synuclein are associated with Parkinson's disease
Mueller, J. C., Fuchs, J., Hofer, A., Zimprich, A., Lichtner, P., Illig, T., Berg, D., Wüllner, U., Meitinger, T., & Gasser, T. (2005) · Annals of Neurology · doi:10.1002/ana.20438 · Cited by 234
α‐Synuclein promoter confers susceptibility to Parkinson's disease
Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van den Broeck, M., De Pooter, T., Cras, P., Crook, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20268 · Cited by 212
Survival Study of Parkinson Disease in Olmsted County, Minnesota
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.1.91 · Cited by 179
Self-citationSilencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi
Sapru, M. K., Yates, J. W., Hogan, S., Jiang, L., Halter, J., & Bohn, M. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.024 · Cited by 173
Touchman, J. W., Dehejia, A. M., Chiba‐Falek, O., Cabin, D. E., Schwartz, J. R., Orrison, B. M., Polymeropoulos, M. H., & Nussbaum, R. L. (2001) · Genome Research · doi:10.1101/gr.165801 · Cited by 133
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<819::aid-mds1009>3.0.co;2-p · Cited by 131
Self-citationCommentary: Meta-analysis of Individual Participants' Data in Genetic Epidemiology
Ioannidis, J. P. A., Rosenberg, P. S., Goedert, J. J., & O'Brien, T. R. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf031 · Cited by 117
Polymorphism of NACP-Rep1 in Parkinson’s disease: An etiologic link with essential tremor?
Tan, E., Matsuura, T., Nagamitsu, S., Khajavi, M., Jankovic, J. J., & Ashizawa, T. (2000) · Neurology · doi:10.1212/wnl.54.5.1195 · Cited by 110
Familial aggregation of Parkinson's disease: The Mayo Clinic family study
Rocca, W. A., McDonnell, S. K., Strain, K. J., Bower, J. H., Ahlskog, J. E., Elbaz, A., Schaid, D. J., & Maraganore, D. M. (2004) · Annals of Neurology · doi:10.1002/ana.20228 · Cited by 101
Self-citationMedical Services Utilization and Prognosis in Parkinson Disease: A Population-Based Study
Parashos, S. A., Maraganore, D. M., O'Brien, P. C., & Rocca, W. A. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.9.918 · Cited by 90
Self-citationFunctional analysis of intra-allelic variation at NACP-Rep1 in the ?-synuclein gene
Chiba‐Falek, O., Touchman, J. W., & Nussbaum, R. L. (2003) · Human Genetics · doi:10.1007/s00439-003-1002-9 · Cited by 87
Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease
Tan, E., Chai, A., Teo, Y., Zhao, Y., Tan, C. E., Shen, H., Chandran, V. R., Teoh, M. L., Yih, Y., Pavanni, R., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000101721.25345.dc · Cited by 82
Causal relation between α synuclein gene duplication and familial Parkinson’s disease
Inserm, U. (2005) · Dkgest of the World Latest Medical Information · Cited by 81
Mellick, G. D., Maraganore, D. M., & Silburn, P. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.078 · Cited by 76
Self-citationMutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease
Parsian, A., Racette, B. A., Zhang, Z. H., Chakraverty, S., Rundle, M. M., Goate, A., & Perlmutter, J. S. (1998) · Neurology · doi:10.1212/wnl.51.6.1757 · Cited by 72
Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan
Izumi, Y., Morino, H., Oda, M., Maruyama, H., Udaka, F., Kameyama, M., Nakamura, S., & Kawakami, H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01557-9 · Cited by 68
Khan, N. L., Graham, E., Dixon, P. H., Morris, C. M., Mander, A., Clayton, D. G., Vaughan, J. R., Quinn, N. P., Lees, A. J., Daniel, S. E., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1027 · Cited by 63
Interaction of α‐synuclein and tau genotypes in Parkinson's disease
Mamah, C., Lesnick, T. G., Lincoln, S., Strain, K. J., de Andrade, M., Bower, J. H., Ahlskog, J. E., Rocca, W. A., Farrer, M. J., & Maraganore, D. M. (2005) · Annals of Neurology · doi:10.1002/ana.20387 · Cited by 47
Self-citationSpadafora, P., Annesi, G., Pasqua, A. A., Serra, P., Candiano, I. C. C., Carrideo, S., Tarantino, P., Civitelli, D., Marco, E. V. D., Nicoletti, G., et al. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00859-0 · Cited by 42
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study
McDonnell, S. K., Schaid, D. J., Elbaz, A., Strain, K. J., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., & Rocca, W. A. (2006) · Annals of Neurology · doi:10.1002/ana.20844 · Cited by 38
Self-citationComplex interactions in Parkinson's disease: A two‐phased approach
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Farrer, M. J., Bower, J. H., Hardy, J., & Rocca, W. A. (2003) · Movement Disorders · doi:10.1002/mds.10431 · Cited by 33
Self-citationKirchner, A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.1.73 · Cited by 32
Cited by
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Structural Variation in the Human Genome and its Role in Disease
Stankiewicz, P., & Lupski, J. R. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-100708-204735 · Cited by 1,201
Metadata
- Authors
- Maraganore, D. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-08-09
- Volume
- 296
- Issue
- 6
- Pages
- 661
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2142286857
- Cited by
- 508
- References
- 53
- FWCI
- 26.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.